CFN Media’s Exclusive Interview with Pascal Biosciences
November 8, 2018
Ryan Allway November 8th, 2018 Exclusive, News, Press Releases, Top Story The cannabis industry is projected to reach $75 billion by 2030, according to Cowen & Co., driven by the legalization of medical and recreational cannabis across a growing number of states. While many investors are familiar with... Read more
Pascal Biosciences Announces Optimization of Cannabinoid-Derived Drug Candidates to Kill Glioblastoma Cells
November 5, 2018
Ryan Allway November 5th, 2018 News, Press Releases VANCOUVER, British Columbia and SEATTLE, Nov. 05, 2018 (GLOBE NEWSWIRE) — Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today announced the peer reviewed publication and upcoming presentation of their recently licensed cannabinoid-derived drug... Read more
Gabriella’s Kitchen Confirms Its Cannabis-Infused alto™ Products Have Launched in Northern California
November 2, 2018
GABY offers a variety of alto™ products including a line infused with cannabis-derived cannabinoids (including CBD and THC) which are part of GABY’s “better-for-you” edibles line, the first such line to be offered, representing an entirely new approach to cannabis-infused products. The initial alto™ products released consist of infused,... Read more
Bloomberg Interviews FSD Pharma for Cannabis Shortage Feature
October 30, 2018
Ryan Allway October 30th, 2018 News, Top News Canada may have legalized adult-use cannabis on October 17, but that doesn’t mean consumers are able to purchase the drug. According to Bloomberg, there are widespread shortages across the country, despite an ample supply of licensed producers awaiting approval from... Read more
Cannabis has long been considered to be one of the best treatments for a variety of different ailments, but new research is showing that the substance may have a large amount of potential to treat various types of cancers. According to one report, the British Journal is looking at... Read more
